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Background: The ability to interrogate circulating tumor cells (CTC) and disseminated tumor cells (DTC) is restricted
by the small number detected and isolated (typically <10). To determine if a commercially available technology
could provide a transcriptomic profile of a single prostate cancer (PCa) cell, we clonally selected and cultured a
single passage of cell cycle synchronized C4-2B PCa cells. Ten sets of single, 5-, or 10-cells were isolated using a
micromanipulator under direct visualization with an inverted microscope. Additionally, two groups of 10 individual
DTC, each isolated from bone marrow of 2 patients with metastatic PCa were obtained. RNA was amplified using
the WT-Ovation™ One-Direct Amplification System. The amplified material was hybridized on a 44K Whole Human
Gene Expression Microarray. A high stringency threshold, a mean Alexa FluorW 3 signal intensity above 300, was
used for gene detection. Relative expression levels were validated for select genes using real-time PCR (RT-qPCR).
Results: Using this approach, 22,410, 20,423, and 17,009 probes were positive on the arrays from 10-cell pools, 5-
cell pools, and single-cells, respectively. The sensitivity and specificity of gene detection on the single-cell analyses
were 0.739 and 0.972 respectively when compared to 10-cell pools, and 0.814 and 0.979 respectively when
compared to 5-cell pools, demonstrating a low false positive rate. Among 10,000 randomly selected pairs of genes,
the Pearson correlation coefficient was 0.875 between the single-cell and 5-cell pools and 0.783 between the
single-cell and 10-cell pools. As expected, abundant transcripts in the 5- and 10-cell samples were detected by
RT-qPCR in the single-cell isolates, while lower abundance messages were not. Using the same stringency, 16,039
probes were positive on the patient single-cell arrays. Cluster analysis showed that all 10 DTC grouped together
within each patient.
Conclusions: A transcriptomic profile can be reliably obtained from a single cell using commercially available
technology. As expected, fewer amplified genes are detected from a single-cell sample than from pooled-cell
samples, however this method can be used to reliably obtain a transcriptomic profile from DTC isolated from the
bone marrow of patients with PCa.
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The development of novel technologies for capturing,
enriching, and preserving exfoliated abnormal cells from
body fluids or effusions as well as methods for concen-
trating the tumor-derived sub-cellular material for use in
biomarker studies is currently a focus in the cancer field.
Our laboratory and others have previously noted the
presence of circulating tumor cells (CTC) in the blood
and disseminated tumor cells (DTC) in the bone marrow
of prostate cancer (PCa) patients at time of radical pros-
tatectomy, in post-radical prostatectomy patients with
no evidence of disease, and in patients with advanced
disease [1-4]. While men with DTC in the bone marrow
are at an increased risk of future disease recurrence,
many will not recur [2]. In addition, PCa is somewhat
unique in the long delay that is often seen between the
treatment of localized disease and the development of
metastases. This suggests that tumor cells can remain
dormant in the bone marrow for years and are subse-
quently “activated” by unknown mechanisms in some
patients, leading to the formation of metastases [5-7].
However, to date there are no known markers to separ-
ate recurrent from indolent CTC/DTC or to distinguish
dormant from senescent cells.
Transcriptomic analysis of CTC/DTC possesses the po-
tential to identify markers that distinguish recurrent from
indolent disease and genes important for tumor dormancy.
However, using standard techniques this approach is
limited by the need to pool multiple DTC to obtain enough
mRNA for amplification [1,2,5]. This approach may com-
bine dormant and indolent DTC, making identification of
dormancy markers difficult or impossible. The primary
challenge of single-cell transcriptome analysis is amplifying
the mRNA to a detectable level while maintaining the
correct sequences and relative signal intensities of the
expressed genes.
Several methods for single-cell transcriptome analysis
have been described. However, these methods are
limited in their potential application due to the require-
ment for high throughput, time constraints, monetary
considerations, and reproducibility. Therefore, we aimed
to develop and validate an efficient, reproducible method
for obtaining a transcriptomic profile from a single cell
using commercially available technologies.
All single-cell transcriptome profiling methods rely on
the creation and amplification of a cDNA library. To be
detected using current technology, available mRNA from
a single cell must be amplified approximately 107-fold.
There are two amplification strategies used: linear amplifi-
cation through in vitro transcription (IVT) and exponen-
tial amplification through a PCR-based method [8-11].
The IVT method is more stringent and reduces the num-
ber of non-specific byproducts formed during amplifica-
tion, but it is time intensive as each round of IVT onlyamplifies the available cDNA approximately 1000-fold.
Through exponential amplification, PCR-based methods
are more time efficient but are challenging to use with low
abundance mRNA due to the potential for amplification
of primer-primer dimers and loss of relative signal inten-
sity through multiple rounds of amplification.
In the method described here, a commercial technol-
ogy is used for amplification of low-abundance mRNA
and a commercially available human oligonucleotide
microarray to profile the transcriptome from a single
PCa cell. Using clonally selected, synchronized single
C4-2B PCa cells, pools of 5 cells, and pools of 10 cells,
we determined that this method is efficient and effective
but is limited predominantly by the abundance of the
mRNA species available for amplification from a single
cell. Herein we describe the usefulness and limitations of
this approach.
Methods
Culture and isolation of individual PCa cells
To obtain a synchronized PCa cell population for ana-
lysis, we clonally selected C4-2B cells and cultured a sin-
gle passage of cells in RPMI 1640 medium (Life Sciences
Technologies Inc.) with 10% FBS. Cells were treated with
30 mg/ml of Aphidicolin (Sigma) 24 h prior to isolation.
Cells were trypsinized and resuspended in RPMI 1640
with 10% FBS. Ten replicates of single, pools of 5, and
pools of 10 cells (a total of 30 samples) were isolated
with glass micropipettes using a TransferManW NK
micromanipulator (Eppendorf ), lysed in a 2 μl drop of
WT-Ovation™ One-Direct Amplification System lysis
buffer (NuGEN) on a siliconized glass slide, and then
stored for a minimum of 2 weeks at −80°C before ampli-
fication. The transfer of cells to lysis buffer was verified
by direct visualization.
Isolation of individual DTC from the bone marrow of PCa
patients
All materials were acquired and used conforming with
IRB-approved protocols at the University of Washington.
DTC were isolated from bone marrow samples of PCa
patients with advanced disease. Ten ml of bone marrow
was aspirated from the iliac crest into a 30 ml syringe
containing 10 ml of 6% sodium citrate. In samples
obtained from patients, bilateral aspirates were obtained
and combined for a total of 20 ml of bone marrow.
Samples were obtained using local anesthesia and taken
from the posterior iliac crest. Processing of samples
commenced within 1–2 hours and was completed within
5 hours.
Cell enrichment
Cell enrichment and isolation was performed as previ-
ously described [12]. Briefly, bone marrow aspirates were
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ml (Accurate Chemical, Westbury, NY). Centrifugation
subsequently yielded a mononuclear cell layer containing
DTC, if present. The MACS system for immunomagnetic
selection (Miltenyi Biotec, Auburn, CA) was then
employed. Anti-CD45 and anti-CD61 antibodies were used
for negative selection, targeting leukocytes, megakaryocytes,
and platelets. Positive selection was then performed with
immunomagnetic beads coated with anti-human epithelial
antigen (HEA) antibodies.
Identification of DTC
For identification and isolation of DTC, the enriched
population was subjected to immunostaining with fluor-
escein isothiocyanate labeled anti-BerEP4 antibodies
(Dako, Carpinteria, CA) which bind a different epitope
on HEA than the anti-HEA antibody used for positive
selection. A phycoerythrin conjugated anti-CD45 anti-
body was also added for identification of leukocytes. The
cells were kept on ice and viewed under fluorescent light
using an inverted microscope. Individual cells were
isolated using a micromanipulator, placed in 2 μl of lysis
buffer from the WT-Ovation™ One-Direct Amplification
System (NuGEN) and stored at −80°C.
Amplification of total RNA from PCa cells
Total RNA was amplified from each sample using the WT-
Ovation™ One-Direct Amplification System (NuGEN)
according to the manufacturer’s directions. The use of an
aluminum cooling block on ice facilitated the handling of
the reaction tubes. The amplified cDNA product purity and
yield was determined by measuring the product’s absorb-
ance at 260, 280, and 340 nm. The size distribution of the
amplified cDNA product was analyzed on an Agilent
Bioanalyzer using the RNA 6000 Pico LabChip with the
mRNA Pico program. The mean fragment size was
determined by creating a fragment on the electro-
pherogram beginning at the start of the fluorescent signal
and ending at a point corresponding to 50% of the total
area. The end size (nt) value for this point was used to rep-
resent the mean fragment size. Post-SPIA modification and
post-amplification work was performed in a separate
workspace.
Real-Time PCR (RT-qPCR)
Amplified cDNA from each sample was used for RT-
qPCR amplification of 10 genes (Additional file 1:
Tables S1). We measured relative gene expression
changes in triplicate reactions using 5 ng cDNA, 0.2 -
μmol/L of each primer, and Power SYBR Green PCR
master mix (Applied Biosystems) in a reaction volume of
10 μL on a 7900HT Real-Time PCR machine (Applied
Biosystems). All reactions were run in triplicate and
assessed for quality and specificity by analysis ofdissociation curves. We normalized mean quantification
cycle value (Cq) for each gene to a housekeeping gene,
RPL13A. We identified poor quality samples using
Dixon’s Q test, a non-parametric test appropriate for
small samples, to identify outliers based on the means of
triplicate gene expression changes of four housekeeping
genes (ACTB, RPL13A, YWHAZ, and GAPDH) [13].
Labeling and hybridization of amplified material on
Agilent chip
Amplified cDNA from each sample and reference pool
were labeled using the BioPrimeW Total Genomic Label-
ing System (Invitrogen™). The reference pool was
prepared by combining equal quantities of total RNA
isolated from LNCaP, DU145, PC3, and CWR22 prostate
epithelial cell lines grown at log phase, amplifying through
two rounds using the MessageAmp™ II aRNA Amplifica-
tion Kit (AmbionW), and converting to first strand cDNA.
Hybridization probes were prepared by combining 6 mg
of Alexa FluorW 3 labeled sample and 1 mg Alexa FluorW
5 labeled reference and denatured at 95C and hybridized
at 63°C on Agilent Human 4x44K microarrays and
processed following the manufacturer’s specifications.
Arrays were scanned on an Agilent DNA Microarray
Scanner.
Gene expression analysis
Graphical examination of raw array signal indicated a
batch effect due to subtle day-to-day variability in sample
processing. We corrected for this effect by separately esti-
mating mean Alexa FluorW 3 and mean Alexa FluorW 5
signal within single-, 5-, and 10-cell arrays between experi-
mental days and adjusting values on the second day by the
estimated difference. We normalized day-effect-corrected
signals within arrays using loess and normal-exponential
background correction with offset 50 and quantile
normalized between arrays separately for single-, 5-, and
10-cell arrays using the Limma package in R [14]. We then
calculated sensitivity and specificity for the single-cell
arrays using both the 5- and 10-cell arrays as the gold
standard. Sensitivity is the proportion of commonly
expressed probes in both array types out of total number
of expressed probes in the gold standard. Specificity is the
proportion of commonly unexpressed probes in both
array types out of total number of unexpressed probes in
the gold standard. Confidence intervals are based on a
Bayesian approach using a uniform prior distribution. The
same analysis was done for arrays from 5-cell pools using
arrays from 10-cell pools as the gold standard. Relative
signal intensity of individual markers was assessed using
the M-ratio, defined as log2 (Alexa Fluor
W 3/Alexa FluorW
5), for all probes detected on all three sets of arrays, with
detection defined as across-array-averaged, day-effect
-adjusted, normalized Alexa FluorW 3 signal greater than
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between the single- and 5-cell, single- and 10-cell, and 5-
and 10-cell arrays. To assess the ability of the single-cell
arrays to accurately order gene expression levels, we also
calculated Spearman correlation of the ranks of M-ratios.
The ability of the single-cell arrays to accurately detect the
relative expression of probes on the same array was
assessed by examining Pearson correlation of ratios of M-
ratios from 10,000 randomly selected probes between each
pair of arrays. Gene set enrichment analysis was applied
for a select set of genes in the single-, 5-, and 10-cell




Cultured C4-2B cells, a PCa line derived from the
LNCaP cell line, were grown, isolated, and amplified as
illustrated (Figure 1). Quality of the amplified genetic
material was assessed in four ways: purity and yield by
spectrophotometer absorbance, gene detection by RT-
qPCR, efficiency of labeling amplified material prior to
microarray hybridization, and standard deviation of oligo
hybridization to microarrays. The range of Abs260/
Abs280 ratios of all samples was found to be 1.9 to 2.0,
indicating high purity. The average amplified cDNA
product yield for single-cell samples was 12.1 +/−
1.9 μg, for 5-cell samples 12.6 +/− 1.8 μg, and for 10-cell
samples 13.5 +/− 2.3 μg. Yields are not expected to be
directly proportional to input amount because, in the
absence of template, one would expect nonspecific
cDNA yields below 4 to 5 μg of product. Using a Dixon’s
Q test we determined that there were no outliers for the
single-, 5-, and 10-cell sample yields. Additionally, mean
fragment sizes of the amplified products assessed on a
Bioanalyzer were not significantly different between 1-,
5- and 10-cell samples. RT-qPCR was performed for 10
genes for all amplified samples. Specific genes andFigure 1 Isolation of individual cells. A. Fluorescently labeled EpCAM po
cell is harvested using a micropipette system (40X).primers used are listed in Additional file 1: Table S1.
Four housekeeping genes (ACTB, RPL13A, YWHAZ,
and GAPDH), were reliably detected in the single-, 5-,
and 10-cell samples. Based on the RT-qPCR results, we
determined that one of the single-cell samples and one
of the 10-cell samples was a failure (Additional file 2:
Table S2). In addition, we determined that the Cq for in-
dividual cells for housekeeping genes was higher than
that of 10 pg of RNA from the same clonal population
suggesting less material was available for amplification
from a live single cell isolated from culture (Additional
file 2: Table S2). For microarray analysis, amplified
cDNA from the single-, 5-, and 10-cell samples and from
a reference pool were labeled using the BioPrimeW Total
Genomic Labeling System (Invitrogen™). Labeling effi-
ciency was defined as the amount of Alexa FluorW 3
label used of amplified RNA. Labeling efficiency was
5.2 ± 1.4 pmol/ng for the single-cell samples, 6.3 ± 1.7
pmol/ng for the 5-cell samples, and 8.6 ± 1.6 pmol/ng
for the 10-cell samples. This indicates that RNA quality
was similar for all three samples, but labeling efficiency
was higher with larger numbers of cells. Once again, a
Dixon’s Q test was used to identify potential outliers
based on labeling efficiency and no significant outliers
were found. To determine if poor quality samples could
be identified based on Alexa FluorW 3 intensity, we
analyzed the changes of distributions of log2(Alexa
FluorW 3) for the 10 replicates in the single-, 5-, and
10-cell samples. Using a Dixon’s Q test based on 25th,
50th, and 75th percentiles, maximum values, and mean
absolute deviations to quantify array performance, we
did not identify additional poor quality samples. The
samples deemed to be of poor quality by any of the four
criteria (purity and yield by spectrophotometer absorb-
ance, gene detection by RT-qPCR, efficiency of labeling
amplified material prior to microarray hybridization, or
the standard deviation of oligo hybridization to
microarrays) were excluded from further analyses.sitive cells are identified and B. Under light microscopy a single C4-2B
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Amplified and Alexa FluorW 3 labeled single-, 5-, and
10-cell samples were hybridized to Agilent 4x44k human
genome microarrays along with Alexa FluorW 5 labeled
reference RNA (Figure 2). A total of 38,695 probes were
present on each array. Previously, we obtained 24,885
positive probes on a reference array, which represents
the average number of probes detected from C4-2B cells
using standard mRNA isolation, amplification, and array
protocols. In this study, 17,009 probes were positive on
the single-cell arrays, 20,423 probes on the arrays from
5-cell pools, and 22,410 probes on the arrays from 10-
cell pools. The sensitivity and specificity of gene detec-
tion on the arrays from single-cell pools were 0.739 and
0.972 respectively when compared to arrays from 10-cell
pools, and 0.814 and 0.979 respectively when compared
to arrays from 5-cell pools, demonstrating a low false
positive rate.
Relative signal intensity
The Pearson correlation between M-ratios on the arrays
from single-cell and 5-cell pools was 0.876 and on the
arrays from single-cell and 10-cell pools was 0.787. The
Spearman correlation between ranks of M-ratios on the
arrays from single-cell and 5-cell pools was 0.842 and on
the arrays from single-cell and 10-cell pools was 0.786.
To test whether gene-to-gene ratios were maintained
across sample type we randomly selected 10,000 pairs of
genes as an approximation to all 133 million pairs of
genes, which we refer to as differences of M-ratios. The
Pearson correlation of differences between M-ratios on
the arrays from cells single and 5-cell pools was 0.856
and on the single-cell and 10-cell pools was 0.780.
Figure 3 shows the global correlation of M-ratios and
difference of M-ratios between single-cell and 5-cell and
single-cell and 10-cell pools. We also conducted an M-
ratio pair-wise correlation analysis for the single cell to
gauge the presence of outliers. Based on the correlation
analysis, we could not find any outliers for the singleFigure 2 Microarray results. Heat map representing magnitude of
Alexa FluorW 3 signal intensity levels. *Indicates removed from
analysis based on quality control.cells (Additional file 3: Table S3). The strong positive
correlations between M-ratios, ranks of M-ratios, and
ratios of M-ratios on the single-cell analyses relative to
the 5- and 10-cell pools indicates that signal intensities,
their ordering, and their relative levels are generally
preserved in the arrays from single-cells. Furthermore
the average 10-cell profile versus each individual cell
profile the pair-wise correlation coefficient ranged from
0.537 to 0.787, suggesting limited variability between the
1 cell profiles.
RT-qPCR results
To determine if RT-qPCR could validate the results of the
gene expression arrays, we assessed the expression of one
epithelial (EPCAM) and five well known prostate epithe-
lial associated genes. We compared the expression levels
relative to RPL13A in each of the single-, 5-, and 10-cell
samples as well as 10 and 100 pg of C4-2B RNA from the
same culture that the other C4-2B cells were isolated from
(Figure 4). For the androgen receptor (AR), epithelial cell
adhesion molecule (EPCAM), and prostate-specific anti-
gen (KLK3), we observed consistency between the single-,
5-, and 10-cell samples. However, there was a decrease in
expression levels for TMPRSS2, FK506-binding protein 5
(FKBP5), and prostatic acid phosphatase (ACPP) respect-
ively in the single-cell samples relative to the 5- and 10-
cell samples. Additionally FKBP5 was not detected in five
5-cell samples and ACPP was not detected in six 5-cell
samples and four 10-cell samples (Figure 4).
Comparison of microarray signal intensity to RT-qPCR
We wished to determine an approximate cut off that
would indicate when there is a loss of fidelity between
the oligo gene expression array Alexa FluorW 3 signal in-
tensity and RT-qPCR. Our results suggest that an Alexa
FluorW 3 signal intensity above the 75th percentile would
be an approximate cut off that we could use to validate
our results using RT-qPCR for the C4-2B samples, rec-
ognizing that there is inconsistency between the oligo la-
beling on the array and the amplicons obtained using
RT-qPCR (Tables 1 and 2). Nonetheless this cutoff is a
useful indicator of fidelity.
Gene set enrichment analysis
To determine which biological pathways were consistent
between the single-, 5-, and 10-cell C4-2B samples, we
performed gene set enrichment analysis. The top 25 bio-
logical pathways are listed in Additional file 4: Table S4
with a FDR q-value < 0.0001. As expected, the top 25
pathways are associated with RNA processing, protein
translation, and mitochondrial activity. The Pearson
correlations for the normalized enrichment scores were
significant at 0.932 and 0.923 for single- versus 5- and
Figure 3 Correlation of M-ratios (top two panels) and difference of M-ratios (bottom two panels) between arrays. The mean M-ratio for
each probe detected on the single-cell arrays was compared to the M-ratio for the same probe on the 5- or 10-cell array. The M-ratio is defined
as log2 (Alexa Fluor
W 3/Alexa FluorW 5).
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The transcriptomic analysis of patient DTC
To validate the method we wished to determine if the
methodology could be used in the analysis of individual
tumor cells isolated from the bone marrow of patients.
Similar to the C4-2B cell samples, 10 individual DTC
from 2 patients were amplified. To determine if there
was a difference in the input material from the patients
relative to the cultured cells we assessed the amplified
fragment sizes. The mean fragment size on theBioanalyzer for 1 C4-2B cell was 610 (range 275–966),
5-cell 493 (range 144–968) and 10-cell 598 (range 178–
1168). For the patient cells it was 193 (range 139–319)
and 224 (range 127–469) respectively (we did not ob-
serve any associations between amplicon size and the
gene expression array results). After amplification the
samples were Alexa FluorW 3 labeled single-cell samples
were hybridized to Agilent 4x44k human genome
microarrays along with Alexa FluorW 5 labeled reference
RNA. A total of 16,039 probes were positive on the pa-
tient sample arrays. Cluster analysis revealed similarities
between the cells isolated within a patient, but not
Figure 4 Real-time PCR results. RT-qPCR results for AR, EPCAM, KLK3, TMPRSS2, FKBP5 and ACPP. Inverse cycle thresholds relative to RPL13A are
shown for single-cell, 5-cell, 10-cell samples as well as 10 pg and 100 pg and unamplified of C4-2B total RNA from the same original culture.
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sion of prostate specific genes from each of 10 individual
DTC isolated from the two PCa patients (2613 and 2679).
The heatmap in Figure 6 shows that each of the top 10
expressed prostate specific genes was in the top 75th per-
centile of genes expressed in these samples. Additionally, to
identify differences between biological pathways present in
the two patient sample sets, using 10,731 known genes to
compare the profiles of each patient by gene set enrichmentanalysis two gene sets were significantly upregulated with a
false discovery rate <25% [15,16]. The two pathways were
the TRKA pathway (binds nerve growth factor and is
implicated in PCa proliferation) and the activation of the
RAC pathway (associated with cell motility).
Discussion
Herein we describe a one-step amplification of mRNA
from a single cancer cell and hybridization to an
Table 1 Detection of six selected genes by RT-qPCR from a total of 9 samples in the 1 and 10 cell category and 10
samples in the 5 cell category
# of samples detected by RT-qPCR Rank percentile (n = 38695 probes)
Gene 1-cell (n = 9) 5-cell (n = 10) 10-cell (n = 9) 1-cell (n = 9) 5-cell (n = 10) 10-cell (n = 9)
AR 8 10 9 99 99 99
KLK3 6 10 9 94 98 95
EPCAM 6 9 9 92 95 95
TMPRSS2 0 4 8 85 89 86
FKBP5 2 5 9 69 60 63
ACPP 0 4 5 50 45 54
Detection was considered as having an inverse Cq of at least −20 relative to RPL13A.
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cially available gene expression array technology. The
amplification technology employed used a linear isother-
mal method to amplify mRNA. Unlike exponential amp-
lification, this linear amplification approach is carried
out by replication of only the original transcripts not
replication of copies. An additional advantage is that the
amplified cDNA can be used directly in RT-qPCR ana-
lysis. The commercially available kit used was employed
based on availability at the start of these studies and
does not compare this to other now commercially avail-
able kits using a similar platform. Using this microarray
platform, approximately 76% of the probes detected in
10-cell pooled samples were detected in the single-cell
samples. This decrease in probes detected and signal in-
tensity appears to be related to the amount of material
available. For those probes that were detected, we found
a high correlation between the relative signal intensity of
detected probes on arrays from single-cell and 10-cell
pools. Additionally, we found a significant correlation
between the single-, 5-, and 10-cell samples using gene
set enrichment analysis.
Many groups have used PCR-based technologies to
analyze a subset of genes from a single cell; however,
screening of thousands of genes is more challenging.
Other groups, notably Kurimoto et al. [10], have isolated
a transcriptomic profile of individual cells; theseTable 2 Detection of six selected genes by RT-qPCR from a to
samples in the 5 cell category
# of samples detected by RT-qPCR
Gene 1-cell (n = 9) 5-cell (n = 10) 10-cell (n =
ACTB 7 7 9
GAPDH 8 10 9
YWHAZ 8 10 9
RPL13A 9 10 9
Detection was considered as having a Cq of <30. Rank percentile represents the av
passed quality control for a given gene with outliers excluded using Dixon’s Q test.methods are extremely effective but are not always avail-
able throughout the greater scientific community and
are labor and time intensive. Similar methods to profile
individual cells are also being developed; Islam et al. [17]
have used highly multiplex RNA-seq to obtain a single-
cell transcriptomic profile on a large number of single
cells. Reproducibility was good; however, as in our study,
the detection level decreased for genes expressed at
lower levels. Additionally, they found a correlation of
0.86 for embryonic stem cells and 0.63 for embryonic
fibroblasts compared to 0.86 for 10 pg of human brain
RNA as a reference. Cann et al., have also used mRNA-
Seq to profile gene expression in CTC [18]. Using
Magsweeper technology to isolate LNCaP cells they
found a high correlation in gene expression (R2 = 0.985)
between Magsweeper and control pools of LNCaP cells.
For LNCaP controls they measured 4622 ± 136 RefSeq
transcripts with ≥10 FPKM. Of 67 CTC from 13
patients, 20 CTC from 4 patients had 2362 ± 865 RefSeq
transcripts with ≥10 FPKM. Using an unsupervised clus-
ter analysis the authors state that only two of 20 CTC
did not cluster with other CTC from the same patient
suggesting limited heterogeneity. However this may be
limited by the number of samples tested and the number
of transcripts available for analysis. While a smaller
number of transcripts were available for analysis using
this mRNA-Seq approach compared to the genetal of 9 samples in the 1 and 10 cell category and 10
Rank percentile (n = 38695 probes)





erage Alexa FluorW 3 intensity from all oligonucleotides on the array that
n = number of samples analyzed.
Figure 5 Cluster analysis of the top 1,000 most variable genes from each of 10 individual DTC isolated from the bone marrow of two
PCa patients (2613 and 2679) with advanced metastatic disease.
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benefits to using mRNA-Seq relative to gene expression
analysis alone.
The importance of using a commercially available
technology accessible to a broad user group is important
as it provides the ability to examine individual cells to
most laboratory based research groups. This is of par-
ticular interest to groups working on CTC/DTC, where
the technology needs to go beyond measuring cell num-
ber to characterizing the molecular profile of individual
cells [7,19]. This is particularly important as tumor cell
heterogeneity could significantly impact the transcriptomicprofile displayed by these cells at different times through-
out the disease process [20]. Tumor cell heterogeneity may
arise due to clonal evolution within a single tumor or
multiple metastatic tumor sites shedding cells. This
heterogeneity restricts our ability to obtain a definitive
transcriptomic profile from CTC/DTC to further characterize
the biological events occurring in response to treatment or the
identification of tumor biomarkers. We have shown that a
commercially available technology could be used to profile
tumor cells grown in culture and cells isolated from the
bone marrow of patients with PCa. These data show that
the technology is available to obtain a significant and
Gene Symbol Gene Name
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7961.139351decudninegordna,nietorpenarbmemsnartetatsorp1APEMP
NKX3-1 NK3 homeobox 1 5068 0.51 96
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Figure 6 Heatmap of the top 10 expressed prostate specific genes from each of 10 individual DTC isolated from the bone marrow of
two PCa patients (2613 and 2679) with advanced metastatic disease.
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isolated from clinical biospecimens.
The caveats associated with the isolation of single cells
from patient samples include: warm ischemia time, cell
viability, and the RNase activity in cancer cells in vivo
relative to somatic cells. While these parameters could
all impact the quality of samples and therefore limit the
transcriptomic profile observed, we have shown that a
transcriptomic profile can be obtained from patient
specimens. Additionally, examining tumor cell hetero-
geneity requires a greater number of single-cell samples
to be analyzed from each patient; e.g., when profiling 10
cells from one patient, sampling 10 patients would now
require 100 samples for analysis. This highlights the im-
portance of a validated and efficient commercially avail-
able detection methodology that limits sample-to-sample
variability and sample quality. A future challenge to in-
crease the utility of this approach will be to automate
the process of isolating cells of interest, possibly using
microfluidic devices [21], and to provide a stage for dir-
ect RNA amplification or RNA-seq methodologies.
Conclusions
While the amount of material available for amplification is
restrictive limiting the number of positive probes on the
single-cell arrays, we found good correlation between rela-
tive signal intensities of probes detected on single-cell
arrays when compared to both 5- and 10-cell arrays.
Therefore, obtaining a transcriptomic profile from a single
cell in culture and from patient biospecimens using com-
mercially available technology is feasible and potentially
useful. In its current form this methodology can be used
for research purposes; however, due to the dramatic
potential increase in sample number per patient, the
successful combination of this technology with novel high-
throughput procedures will be required for clinical utility.Additional files
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one cell. Based on the Dixon test for the correlation coefficients, the p-
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data: The microarray data for these experiments have been deposited in
the Gene Expression Omnibus database (available at http://www.ncbi.
nlm.nih.gov/geo) under accession number GSE38416.
Additional file 4: Table S4. Gene Set Enrichment Analysis (GSEA) of
single-, 5-, and 10-cell samples. GO = Gene Ontology; NES = Normalized
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gene set is overrepresented at the extremes of the entire ranked list
(n = 925).
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